Clarke v. Bayer HealthCare Pharmaceuticals, Inc. et al

Filing 10

CONDITIONAL TRANSFER ORDER (CTO-45) by the United States Judicial Panel on Multidistrict Litigation TRANSFERRING CASE to the United States District Court for the Northern District of Ohio, MDL No. 1909. (tn, COURT STAFF) (Filed on 3/30/2010)

Mar 10, 2010
By Darion Payne on Mar 25, 2010

UNITED STATES JUDICIAL PANEL on MULTIDISTRICT LITIGATION IN RE: GADOLINIUM CONTRAST DYES PRODUCTS LIABILITY LITIGATION (SEE ATTACHED SCHEDULE) CONDITIONAL TRANSFER ORDER (CTO-45) On February 27, 2008, the Panel transferred 20 civil actions to the United States District Court for the Northern District of Ohio for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. § 1407. See 536 F.Supp.2d 1380 (J.P.M.L. 2008). Since that time, 208 additional actions have been transferred to the Northern District of Ohio. With the consent of that court, all such actions have been assigned to the Honorable Dan A. Polster. It appears that the actions on this conditional transfer order involve questions of fact that are common to the actions previously transferred to the Northern District of Ohio and assigned to Judge Polster. Pursuant to Rule 7.4 of the Rules of Procedure of the Judicial Panel on Multidistrict Litigation, 199 F.R.D. 425, 435-36 (2001), these actions are transferred under 28 U.S.C. § 1407 to the Northern District of Ohio for the reasons stated in the order of February 27, 2008, and, with the consent of that court, assigned to the Honorable Dan A. Polster. This order does not become effective until it is filed in the Office of the Clerk of the United States District Court for the Northern District of Ohio. The transmittal of this order to said Clerk shall be stayed 14 days from the entry thereof. If any party files a notice of opposition with the Clerk of the Panel within this 14-day period, the stay will be continued until further order of the Panel. FOR THE PANEL:
Mar 25, 2010

MDL No. 1909

___________________________ Jeffery N. Lüthi Clerk of the Panel I hereby certify that this instrument is a true and
correct copy of the original on file in my office. Attest: Geri M. Smith, Clerk U.S. District Court Northern District of Ohio By: s/Renee Schumitsh Deputy Clerk

IN RE: GADOLINIUM CONTRAST DYES PRODUCTS LIABILITY LITIGATION SCHEDULE CTO-45 - TAG-ALONG ACTIONS DIST. DIV. C.A. # CASE CAPTION

MDL No. 1909

CALIFORNIA NORTHERN CAN 3 10-618 Celeste Lee, et al. v. Bayer Healthcare Pharmaceuticals, Inc., et al. CAN 3 10-726 Katherine Dennison, et al. v. Bayer Healthcare Pharmaceuticals, Inc., et al. CAN 3 10-728 Antonia Mark v. Bayer Healthcare Pharmaceuticals, Inc., et al. CAN 3 10-809 Sharifah Clarke v. Bayer Healthcare Pharmaceuticals, Inc., et al. ILLINOIS NORTHERN ILN 1 10-996 Adolphus Jones, Jr., etc. v. Mallinckrodt, Inc., et al.